Price T Rowe Associates Inc Infinity Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $29,277 - $82,665	-34,444 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $3,348 - $6,048	-1,800 Reduced 4.97%	34,444 $77,000
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $16,264 - $40,874	-10,700 Reduced 22.79%	36,244 $124,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $20,599 - $26,871	7,744 Added 19.76%	46,944 $140,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.77 $41,160 - $108,584	39,200 New	39,200 $83,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.